If you are interested in generating novel human antibodies with good developabilty contact us at email@example.com
Since initiating our first milestone-based therapeutic antibody partnership in October 2012, IONTAS have successfully completed multiple antibody discovery projects with over 20 USA, European and Far East-based partners.
Some of our recent partnerships:
We have also granted licenses to our antibody phage display library technology which has underpinned this success. For example, we granted an exclusive license for an antibody phage display library to Agenus, an immunology company engaged in the discovery and development of novel checkpoint modulators, vaccines and adjuvants to treat cancer and other diseases.
IONTAS has been granted approval for French Partners to receive
If you are interested in generating novel human antibodies with good developability contact:
Neil Butt, CBO